YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Rising U.S. interest rate expectations, highlighted by the St. Louis Fed hinting at possible hikes over the next 6 to 9 months, keep pressure on expensive, story driven assets. That focus on higher borrowing costs puts a premium on medical…
The Zacks Medical – Products industry has entered the latter half of 2026 with a fundamentally constructive demand backdrop, despite persistent cost and execution pressures. Across the industry, recurring themes include resilient healthcar…
Regulatory setback hits Trulieve Cannabis The decision by DEA Chief Judge Derek Julius to pause the federal cannabis rescheduling case immediately weighed on sector sentiment, with Trulieve Cannabis (TRLV) moving lower as investors reasses…
[Decline in Revenue of Recreational Marijuana] Douglas Rissing * Multi-state operators nosedived Wednesday as they deal with the aftermath of a DEA administrative law judge's order issuing a stay in a hearing that could move marijuana to a…
Trulieve Cannabis falls after the Drug Enforcement Administration pauses pending rescheduling proceedings for a case that could federally recognize cannabis for medical use. Continue Reading
Cannabis stocks haven't exactly been the hottest corner of the market in 2026. But two names have quietly outpaced the S&P 500. Trulieve Cannabis (NYSE: TRLV) and Cronos Group (NASDAQ: CRON) have both gained roughly 27% this year through S…
[White House and Biden Administration Politics and Policy - Legalize Marijuana] Douglas Rissing A federal appeals court has denied a request by two parties that sought to block the Trump administration's plan to reschedule marijuana for me…
TALLAHASSEE, Fla., Sept. 2, 2026 /PRNewswire/ -- Trulieve Cannabis Corp. (NYSE: TRLV) ("Trulieve" or "the Company"), a leading and top-performing medical cannabis company in the U.S., today announced planned event participation in Septembe…
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE…
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE…
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, Aug. 18, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE…
Key Points Interested in Trulieve Cannabis Corp.? Here are five stocks we like better. Second-quarter performance was strong operationally: Trulieve reported $271 million in revenue, $98 million in adjusted EBITDA and $32 million in free c…
Key Points Limited-license states often favor established cannabis operators. Scale and positive cash flow create lasting competitive advantages. Early positioning could matter more than federal legalization.10 stocks we like better than G…
On Tuesday, Green Thumb Industries GTBIF reported impressive second-quarter 2026 results, with earnings and sales beating consensus estimates. The U.S.-based cannabis company reported EPS of 2 cents per share, up from the 1-cent loss repor…
Investing in the cannabis sector means navigating a fast-moving landscape of corporate restructurings, consolidations, and massive regulatory shifts. Trulieve Cannabis (NYSE: TRLV) and Vireo Growth (OTC: VREOF), formerly Goodness Growth Ho…
Key Points 136,811 shares sold directly by Trulieve's Chairman and CEO on June 26, 2026, for a transaction value of approximately $1.2 million based on a price of $8.76 per share. All shares sold were from direct holdings; no indirect or e…
Kim Rivers, the Chairman and CEO of Trulieve Cannabis Corp. (NYSE:TRLV), disclosed the direct sale of 136,811 shares for approximately $1.2 million on June 26, 2026, according to the SEC Form 4 filing. Transaction summary Metric Value Shar…
Trulieve Cannabis (NYSE: TRLV) just accomplished something no other U.S. cannabis operator has managed to do. Earlier this month, the company became the first U.S. plant-touching cannabis business to list on the New York Stock Exchange. Th…
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company's earnings. A caller asked for Cramer's opinion of the company,…
Shares of Green Thumb Industries GTBIF, one of the largest cannabis operators in the United States, have gained 17.5% over the past three months, outperforming its cannabis peers. This rally has been driven by improved regulatory sentiment…
The marijuana industry hit a major milestone last week. While much of the focus was on SpaceX and its IPO, there was also big news in the pot market. Trulieve Cannabis (NYSE: TRLV) is now trading on the New York Stock Exchange under the ti…
Last week, Trulieve Cannabis (OTC: TCNNF) (NYSE:TRLV) became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol "TRLV." Although a publicly traded company moving up to the NYS…
Key Points Trulieve has moved up to the NYSE. More institutional capital could now enter the cannabis sector. Financial normalization is advancing, but risks persist.10 stocks we like better than Trulieve Cannabis › Last week, Trulieve Can…
Trulieve Makes History as the First US Cannabis Company to Trade on the NYSE - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap…
Trulieve Will Become the First U.S. Cannabis Company to List on the NYSE - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap her…